ExodusPoint Capital Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

ExodusPoint Capital Management’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,014	Closed	-$154K	–	2266
2023 Q2	$154K	Buy	+17,014	New	+$150K	﹤0.01%	1715
2022 Q2	–	Sell	-240,515	Closed	-$1.92M	–	2603
2022 Q1	$1.92M	Buy	240,515 +85,481	+55%	+$543K	0.02%	800
2021 Q4	$868K	Buy	+155,034	New	+$1.16M	0.01%	1150

Other funds holding PNT

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ExodusPoint Capital Management's PNT Position: Q3 2023 in Review

ExodusPoint Capital Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q3 2023, closing a stake of 17,014 shares — an estimated $154K sold.

ExodusPoint Capital Management first reported a position in PNT in Q4 2021 and held it in 3 quarters. The position peaked at $1.92M in Q1 2022. 125 funds tracked by Wall St. Rank hold PNT as of Q3 2023.

ExodusPoint Capital Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 17,014 POINT Biopharma Global Inc. Common Stock shares in Q3 2023, an estimated $154K.
ExodusPoint Capital Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2021 and held it in 3 quarters.
ExodusPoint Capital Management's POINT Biopharma Global Inc. Common Stock position peaked at $1.92M in Q1 2022.
125 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q3 2023.

Based on ExodusPoint Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.